These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34790229)
81. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy. Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721 [TBL] [Abstract][Full Text] [Related]
82. The unique molecular mechanism of diabetic nephropathy: a bioinformatics analysis of over 250 microarray datasets. Zhou LT; Zhang ZJ; Cao JY; Chen H; Zhu YS; Wu X; Nawabi AQ; Liu X; Shan W; Zhang Y; Zhang XR; Xue J; Hu L; Wang SS; Wang L; Sun ZX Clin Kidney J; 2021 Jun; 14(6):1626-1638. PubMed ID: 34084458 [TBL] [Abstract][Full Text] [Related]
83. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling. Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118 [TBL] [Abstract][Full Text] [Related]
84. Immune-related gene Deng YJ; Li Z; Wang B; Li J; Ma J; Xue X; Tian X; Liu QC; Zhang Y; Yuan B Front Genet; 2023; 14():1219894. PubMed ID: 37600656 [No Abstract] [Full Text] [Related]
85. Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats. Li S; Xu G Evid Based Complement Alternat Med; 2022; 2022():6239829. PubMed ID: 35754685 [TBL] [Abstract][Full Text] [Related]
86. Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy. Hou R; Gao L; Long J; Cao J; Yin T; Xu J Med Sci Monit; 2023 Nov; 29():e940847. PubMed ID: 37964514 [TBL] [Abstract][Full Text] [Related]
87. The immune-inflammation factor is associated with diabetic nephropathy: evidence from NHANES 2013-2018 and GEO database. Wang Y; Zhao SY; Wang YC; Xu J; Wang J Sci Rep; 2024 Aug; 14(1):17760. PubMed ID: 39085362 [TBL] [Abstract][Full Text] [Related]
88. Multiple-microarray analysis for identification of hub genes involved in tubulointerstial injury in diabetic nephropathy. Zeng M; Liu J; Yang W; Zhang S; Liu F; Dong Z; Peng Y; Sun L; Xiao L J Cell Physiol; 2019 Sep; 234(9):16447-16462. PubMed ID: 30761531 [TBL] [Abstract][Full Text] [Related]
89. Screening of Diabetic Nephropathy Progression-Related Genes Based on Weighted Gene Co-expression Network Analysis. Yu L; Tao H Biochem Genet; 2023 Feb; 61(1):221-237. PubMed ID: 35834115 [TBL] [Abstract][Full Text] [Related]
90. Screening of key genes associated with m6A methylation in diabetic nephropathy patients by CIBERSORT and weighted gene coexpression network analysis. Yin S; Li W; Wang J; Wu H; Hu J; Feng Y Am J Transl Res; 2022; 14(4):2280-2290. PubMed ID: 35559414 [TBL] [Abstract][Full Text] [Related]
91. Integrating network pharmacology, molecular docking and simulation approaches with machine learning reveals the multi-target pharmacological mechanism of Zhang X; Chao P; Zhang L; Lu J; Yang A; Jiang H; Lu C J Biomol Struct Dyn; 2024 Feb; ():1-17. PubMed ID: 38379386 [TBL] [Abstract][Full Text] [Related]
92. Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers. Tu C; Wei L; Wang L; Tang Y Diabetes Metab Syndr Obes; 2022; 15():907-920. PubMed ID: 35359345 [TBL] [Abstract][Full Text] [Related]
93. APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment. Yu K; Li S; Wang C; Zhang Y; Li L; Fan X; Fang L; Li H; Yang H; Sun J; Yang X Front Endocrinol (Lausanne); 2023; 14():1102634. PubMed ID: 36891052 [TBL] [Abstract][Full Text] [Related]
94. Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis. Wang Y; Zhao M; Zhang Y Bioengineered; 2021 Dec; 12(1):5386-5401. PubMed ID: 34424825 [TBL] [Abstract][Full Text] [Related]
95. Machine learning-based metabolism-related genes signature and immune infiltration landscape in diabetic nephropathy. Zhang H; Hu J; Zhu J; Li Q; Fang L Front Endocrinol (Lausanne); 2022; 13():1026938. PubMed ID: 36482994 [TBL] [Abstract][Full Text] [Related]
96. Unveiling diabetic nephropathy: a novel diagnostic model through single-cell sequencing and co-expression analysis. Wang G; Zhao J; Zhou M; Lu H; Mao F Aging (Albany NY); 2024 Jul; 16(13):10972-10984. PubMed ID: 38968594 [TBL] [Abstract][Full Text] [Related]
97. Identification of a novel four-gene diagnostic signature for patients with sepsis by integrating weighted gene co-expression network analysis and support vector machine algorithm. Li M; Huang H; Ke C; Tan L; Wu J; Xu S; Tu X Hereditas; 2022 Feb; 159(1):14. PubMed ID: 35184762 [TBL] [Abstract][Full Text] [Related]
98. From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System. Qiu Y; Tang J; Zhao Q; Jiang Y; Liu YN; Liu WJ J Diabetes Res; 2023; 2023():3931043. PubMed ID: 37287620 [TBL] [Abstract][Full Text] [Related]